Showing 491-500 of 646 results for "".
Choosing or Evaluating Investment Advisors
https://practicaldermatology.com/topics/practice-management/choosing-or-evaluating-investment-advisors/20566/Tips to help you make the best choice.The Year in Aesthetics
https://practicaldermatology.com/topics/practice-management/the-year-in-aesthetics/20399/A look at innovations and approvals in cosmetic dermatology in 2017.What to Look for in an Investment Advisor
https://practicaldermatology.com/topics/practice-management/what-to-look-for-in-an-investment-advisor/21018/Avoid choosing the wrong firm.Enhancing Treatment Adherence
https://practicaldermatology.com/topics/practice-management/enhancing-treatment-adherence/21083/Devising a strategy to engage patients in their treatment regimen for better results.Ugh, I've Been Yelp'd!
https://practicaldermatology.com/topics/practice-management/ugh-ive-been-yelpd/21102/Clinicians bugged by powerful review sites should know physicians have options.Teledermatology: The Present State of Dermatology's Future
https://practicaldermatology.com/topics/practice-management/teledermatology-the-present-state-of-dermatologys-future/21439/Biologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/Update on Oral Contraceptive Therapy in Acne
https://practicaldermatology.com/topics/general-topics/update-on-oral-contraceptive-therapy-in-acne/21582/While OCPs can be effective against acne, it is important to understand the risks and identify ideal candidates for therapy.Case Report: Henoch-Schönlein Purpura in an Adult; Resident Salary Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-henoch-schnlein-purpura-in-an-adult-resident-salary-report/20909/Saving Medical Dermatology: Biologics and the Future of Patient Care
https://practicaldermatology.com/topics/practice-management/saving-medical-dermatology-biologics-and-the-future-of-patient-care/21211/Although prescription rates lag, biologic agents may hold the key to sustaining the specialty.